corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 126 of 144 pages ‹ First  < 124 125 126 127 128 >  Last ›

HSL1086
Heil E.
Frist Predicts Passage Of Medicare Reform Legislation ...
2003 Apr 29

HSL1233
Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP.
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
CMAJ 2003 Apr 29; 168:(9):1133-7
http://www.cmaj.ca/cgi/content/full/168/9/1133

HSL1082
Richwine L.
US warns drug makers about doctor payments, gifts
Reuters 2003 Apr 28

HSL1083
Elliott V.
FDA chief pledges changes to direct-to-consumer advertising guidelines
AMNews 2003 Apr 28
http://www.ama-assn.org/amednews/2003/04/28/hlsd0428.htm

HSL1084
Dr Mercola.
Drug Companies Engage in Illegal Sales Practices: U.S. Issues Warning
Mercola.com 2003 Apr 28

HSL17929
Pear R
U.S. Warns Drug Makers on Illegal Sales Practices
The New York Times 2003 Apr 28
http://www.nytimes.com/2003/04/28/us/us-warns-drug-makers-on-illegal-sales-practices.html?pagewanted=1?pagewanted=1

HSL1081
Pollack A.
Talking Up a Drug for This (and That)
The New York Times 2003 Apr 27
http://www.nytimes.com/2003/04/27/business/talking-up-a-drug-for-this-and-that.html?scp=9&sq=

HSL1079
Kaufman M.
FDA Says It Can Force Change in Drug Sales Status
Washington Post 2003 Apr 26

HSL1080
Confessions of a ten-a-day man
The Guardian 2003 Apr 26
http://www.guardian.co.uk/society/2003/apr/26/health.healthandwellbeing

HSL18180
Dyer O.
Drug companies pay out millions after overcharging Medicaid.
BMJ 2003 Apr 26; 326:(7395):900
http://www.ncbi.nlm.nih.gov/pubmed/12714466

HSL10503
Figueras A, Laporte JR.
Failures of the therapeutic chain as a cause of drug ineffectiveness.
BMJ 2003 Apr 26; 326:(7395):895-6
http://www.bmj.com/cgi/content/full/326/7395/895

HSL1076
Kramer T.
Practitioners and the Pharmaceutical Industry
2003 Apr 25

HSL1075
Hallam K.
Amgen Becomes No. 2 Grassley Donor as Aranesp Debated
2003 Apr 24

HSL1077
Dr Mercola.
Are Drug Companies Next Target After Tobacco?
Mercola.com 2003 Apr 24

HSL1078
The Drugs Industry: Where The Money Is - Is Big Pharma the next target for attack?
The Economist 2003 Apr 24

HSL1070
Hallam K.
Lilly, Merck, Drug Lobby Fight Price Cuts by States
2003 Apr 23

HSL1071
Petersen M.
Drug Makers Expand Their Medicaid Role
The New York Times 2003 Apr 23

HSL17926
Tanner L
Medical journal blasts early end of drug trial: Stopping study for financial reasons unethical, editors say
The Associated Press 2003 Apr 23

HSL1072
MacPherson K.
Pharmacia denounced for halting drug study : Research questioned its medicine's value
Star-Ledger Staff 2003 Apr 23

HSL1073
Martinez B.
Merck Kills Medco IPO Plan,Will Spin Off Unit to Holders : Drug Firm Says Market
THE WALL STREET JOURNAL 2003 Apr 23

HSL1074
Hallam K.
Sen. Kennedy to Press for $700 Bln Prescription Drug Proposal
2003 Apr 23

HSL18186
Psaty BM, Rennie D.
Stopping medical research to save money: a broken pact with researchers and patients.
JAMA 2003 Apr 23-30; 289:(16):2128-31
http://jama.ama-assn.org/cgi/content/full/289/16/2128

HSL1065
McGinley L.
Dispute Over Anemia Drug Is Dragged to Capitol Hill: Amgen, J&J Take 18-Year Fight For Market Control to Legislators
The Wall Street Journal 2003 Apr 22

HSL1066
Kolata G.
Hormone Studies: What Went Wrong?
The New York Times 2003 Apr 22
http://www.nytimes.com/2003/04/22/science/hormone-studies-what-went-wrong.html

HSL1067
Langone J.
Reducing Torment of PMS
The New York Times 2003 Apr 22
http://www.nytimes.com/2003/04/22/health/books-on-health-reducing-torment-of-pms.html

HSL1069
Journal Criticizes Halting Drug Study : Top Medical Journal Condemns Pharmaceutical Industry Over Halted Blood
2003 Apr 22

HSL1064
Pharmaceutical firm cuts drug sales to Canada to fight cross-border buying
Associated Press 2003 Apr 21

HSL1059
Templeton S.
Drugs firms 'cure the rich' claim
Sunday Herald 2003 Apr 20

HSL1060
Elmore C.
What you need to know about pill pitchers
Palm Beach Post 2003 Apr 20

HSL10490
Links.
Moves to eliminate 'anticompetitive' practices in the supply of prescription-only veterinary medicines.
Vet Rec 2003 Apr 19; 152:(16):482-4

HSL1058
Peirol P.
Benefits in sick bay
2003 Apr 18

HSL1055
Harris G.
Bitter Pill: 'Branded Generics' Eat Into Drug Makers' Profits: Generic Drug Makers Use Altered Copies To Outmaneuver Patents in Legal Battles
Wall Street Journal 2003 Apr 17

HSL1056
Ripping Off the Rights of Children: Drug Companies are Enlisting the Help of Heavy Hitters to Protect Themselves from Liability
PRNewswire 2003 Apr 17

HSL1057
Petersen M.
Bayer Agrees to Pay U.S. $257 Million in Drug Fraud
The New York Times 2003 Apr 17
http://www.nytimes.com/2003/04/17/business/17DRUG.html

HSL18181
Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW.
Adverse drug events in ambulatory care.
N Engl J Med 2003 Apr 17; 348:(16):1556-64
http://content.nejm.org/cgi/content/abstract/348/16/1556

HSL18182
Iglehart JK.
Medicare and drug pricing.
N Engl J Med 2003 Apr 17; 348:(16):1590-7
http://content.nejm.org/cgi/content/extract/348/16/1590

HSL1051
Christensen D.
FDA Reorganization Intended to Streamline Review Process for Biologics
Journal of the National Cancer Institute, 2003 Apr 16; 95:(8):576-577
http://jnci.oxfordjournals.org/cgi/content/extract/95/8/576

HSL1052
Frost G.
Bayer Agrees to Biggest Medicaid Fraud Settlement
USA Today 2003 Apr 16
http://www.usatoday.com/money/industries/health/drugs/2003-04-16-drug-settlement_x.htm

HSL1053
Glaxo and Bayer Settle U.S. Medicaid Fraud Charges
REUTERS 2003 Apr 16

HSL1054
Dotinga R.
Mental Illness Strikes Babies, Too
HealthScoutNews 2003 Apr 16

HSL1129
Little Pharma is a business: Get Used To The Idea
2003 Apr 16

HSL5175
Berwick DM.
Disseminating innovations in health care.
JAMA 2003 Apr 16; 289:(15):1969-75
http://jama.ama-assn.org/cgi/content/full/289/15/1969

HSL18172
West R, Borden EK, Collet JP, Rawson NS, Tonks RS.
A national drug agency.
CMAJ 2003 Apr 15; 168:(8):962-3
http://www.cmaj.ca/cgi/content/full/168/8/962-c

HSL1203
Jorgensen J, Djurhuus JC.
[Openness in the cooperation between physicians and private corporations]
Ugeskr Laeger. 2003 Apr 14; 165:(16):1642-5

HSL1050
Pear R.
US to Review Research at Hospitals for Veterans Nationwide
The New York Times 2003 Apr 13
http://www.nytimes.com/2003/04/13/national/13VETS.html

HSL1049
Gottlieb S.
CDC reports first case of vancomycin resistant Staphylococcus aureus
BMJ 2003 Apr 12
http://www.bmj.com/cgi/content/extract/326/7393/783/a

HSL287
Anand G.
Drug Debate: New Antipsychotics Pose a Quandary For FDA, Doctors--- Eli Lilly's Big Seller, Zyprexa, Can Help Schizophrenics; Is It Linked to Diabetes? --- Warnings Abroad, Not in U.S.
Wall Street Journal 2003 Apr 11

HSL1045
Pierson R.
Stroke risk cited in widely used drug
Reuters 2003 Apr 11
http://web.archive.org/web/20030422094006/http://www.boston.com/dailyglobe2/101/nation/Stroke_risk_cited_in_widely_used_drugP.shtml

HSL1047
McGregor G.
MPs to probe drug rule that limits competition
Ottawa Citizen / Canada.Com 2003 Apr 11

HSL1048
Skidmore S.
Medical Partners gives reps access to doctors: For a fee, company manages sales visits
The Florida Times-Union 2003 Apr 11

HSL18163
Luis Jódar F, LaForce M, Ceccarini C, Aguado T, Granoff DM
Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries
Lancet 2003 Apr 10; 361:(9370):
http://image.thelancet.com/extras/02art7254web.pdf

HSL1042
Calmes J.
PhRMA Fights Petition to Force State to Act
THE WALL STREET JOURNAL 2003 Apr 9

HSL1043
Gellene D.
Drug-Firm Rivalry Spills Into Congress
Los Angeles Times 2003 Apr 9
http://articles.latimes.com/2003/apr/09/business/fi-amgen9

HSL1044
NZMA calls for ban on DTCA
2003 Apr 9

HSL1040
Fidelman C.
Drug company pitches in Private-Public partnership. Will spend $3 million in government-run diabetes-prevention program
The Gazette 2003 Apr 8

HSL1041
Marshall E.
Despite Negative Impact of WHI and HERS II Studies, the Hormone Replacement Therapy Market will Experience Robust Growth
Decision Resources, Inc. 2003 Apr 8

HSL1039
Angier N.
'Enough': The Dangers of Genetic Technologies
2003 Apr 6

HSL1038
Cohen P.
Visions and Revisions of Child-Raising Experts
The New York Times 2003 Apr 5
http://www.nytimes.com/2003/04/05/books/visions-and-revisions-of-child-raising-experts.html?pagewanted=all

HSL1037
White V.
Lawmakers Accuse FDA of Siding with Industry on Reimportation From Canada
2003 Apr 4

HSL1036
Attitudes to Government Regulation Vary Greatly for Different Industries
2003 Apr 2

HSL1093
FDA inquiry needed
2003 Apr 2

HSL1035
McGregor G.
Victory for Big Drug Makers MPs shelve review of policy that helps keep generic rivals off the market
Ottawa Citizen 2003 Apr 1

HSL5848
Toop L, Richards D, Dowell T.
The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand.'Possums in the headlights?'.
Br J Gen Pract. 2003 Apr 1; 53:(489):342-5

HSL18183
Gafni A, Birch S.
Inclusion of drugs in provincial drug benefit programs: Should
CMAJ 2003 Apr 1; 168:(7):849-51
http://www.cmaj.ca/cgi/content/full/168/7/849

HSL18184
Square D.
Does that free sleeve of golf balls demean the profession?
CMAJ 2003 Apr 1; 168:(7):884
http://www.cmaj.ca/cgi/content/full/168/7/884

HSL1210
Gershell LJ, Atkins JH.
A brief history of novel drug discovery technologies.
Nat Rev Drug Discov 2003 Apr; 2:(4):321-7
http://www.nature.com/cgi-taf/DynaPage.taf?file=/nrd/journal/v2/n4/abs/nrd1064_fs.html&dynoptions=doi1114934034

HSL1221
Drack G, Kuhn HP, Haller U; Committee for Quality Preservation of the Swiss Society of Gynaecology and Obstetrics.
[Is continuing medical education under suspicion of corruption? Contribution to the discussion by the Committee for Quality Preservation of the Swiss Society of Gynaecology and Obstetrics]
Gynakol Geburtshilfliche Rundsch 2003 Apr; 43:(2):111-7
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=GGR43111

HSL1222
Donnan GA, Davis SM, Kaste M; International Trial Subcommittee of the International Stroke Liaison Committee, American Stroke Association.
Recommendations for the relationship between sponsors and investigators in the design and conduct of clinical stroke trials.
Stroke 2003 Apr; 34:(4):1041-5
http://stroke.ahajournals.org/cgi/content/full/34/4/1041

HSL1227
Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS.
The quantity and quality of scientific graphs in pharmaceutical advertisements.
J Gen Intern Med 2003 Apr; 18:(4):294-7
http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0884-8734&date=2003&volume=18&issue=4&spage=294

HSL1253
A review of new drugs and indications in 2002: financial speculation or better patent care?
Prescrire Int 2003 Apr; 12:(64):74-7

HSL1515
Prosser H, Walley T.
Understanding why GPs see pharmaceutical representatives: a qualitative interview study.
Br J Gen Pract 2003 Apr; 53:(489):305-11
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314573/?tool=pubmed

HSL10283
Gaba MM.
Federal regulation in the absence of prescription drug legislation: the Bush administration's proposal to speed generics to market.
Tissue Eng 2003 Apr; 9:(2):385-7
http://www.liebertonline.com/doi/abs/10.1089%2F107632703764664855

HSL10429
Zolpidem: now classified as a psychotropic at risk of abuse.
Prescrire Int 2003 Apr; 12:(64):60

HSL10481
McManus P, Mant A, Mitchell P, Britt H, Dudley J.
Use of antidepressants by general practitioners and psychiatrists in Australia.
Aust N Z J Psychiatry 2003 Apr; 37:(2):184-9
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1440-1614.2003.01132.x

HSL10482
Erlich H, Bonnet J, Frueh FW, Bertrand P, Schmitz G, Salvatore G, Little S, Lambert C, Baranova E, Siest G.
Pharmacogenetics: from bench to bedside.
Clin Chem Lab Med 2003 Apr; 41:(4):610-4

HSL10485
Wyllie MG.
The phosphodiesterase inhibitor 'war'.
BJU Int 2003 Apr; 91:(6):573-4
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1464-410X.2003.04115.x

HSL10501
Carrasquillo O, Goodman RL.
Pharma's bad karma: Resistance is not futile.
J Gen Intern Med 2003 Apr; 18:(4):315-6
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.2003.30290.x

HSL10502
Shi CW, Asch SM, Fielder E, Gelberg L, Brook RH, Leake B, Shapiro MF, Dowling P, Nichol M.
Usage patterns of over-the-counter phenazopyridine (pyridium).
J Gen Intern Med 2003 Apr; 18:(4):281-7
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.2003.20709.x

HSL10516
Blazquez A, Arias J, Mateos-Campos R.
Trends in the use of antituberculosis drugs in Spain 1993-1998.
Pharmacoepidemiol Drug Saf 2003 Apr-May; 12:(3):227-36

HSL10529
Holdsworth MT.
Pediatric drug research--the road less traveled.
Ann Pharmacother 2003 Apr; 37:(4):586-91
http://www.theannals.com/cgi/content/full/37/4/586

HSL10535
Shader RI, Greenblatt DJ.
The safety of over-the-counter drugs: some reflections and unanswered questions.
J Clin Psychopharmacol 2003 Apr; 23:(2):111-2
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0271-0749&volume=23&issue=2&spage=111

HSL19518
Final Compliance Program Guidance for Pharmaceutical Manufacturers
U.S. HHS Office of the Inspector General. 2003 Apr
oig.hhs.gov/.../complianceguidance/042803pharmacymfgnonfr.pdf

HSL1027
Carr G.
Climbing the helical staircase
The Economist 2003 Mar 27
http://www.economist.com/surveys/displayStory.cfm?story_id=1647556

HSL1026
FDA Chief Seeks More Balance in Drug Ads
The LA Times 2003 Mar 25
http://articles.latimes.com/2003/mar/25/business/fi-rup25.6

HSL1025
Drug argument embroils psychiatrists, pharm cos: Critics question whether medication trumps other treatments
CNN 2003 Mar 24
http://www.cnn.com/2003/HEALTH/conditions/03/24/health.psychiatry.reut/index.html

HSL19923
Elgin B, Mullaney TJ
Search Engines are picking steam
Business Week Online 2003 Mar 24
http://www.rankforsales.com/news/001-seo-mar-21-03.html

HSL1024
Stone A.
LScan helps drug cos. stem their paper trail
Philadelphia Business Journal 2003 Mar 21
http://philadelphia.bizjournals.com/philadelphia/stories/2003/03/24/focus2.html?page=2

HSL10426
Veryard C.
Russian Pharma-Marcus Evans conference.
IDrugs 2003 Mar 20-21; 6:451-453
http://www.biomedcentral.com/1369-7056/6/451

HSL1415
Jureidini JN, Tonkin AL.
Clinical practice guidelines for depression in young people.
Med J Aust 2003 Mar 17; 178:(6):300
http://www.mja.com.au/public/issues/178_06_170303/letters_170303-5.html

HSL18188
Nelson MR.
The verdict from ALLHAT.
Med J Aust 2003 Mar 17; 178:(6):304
http://www.mja.com.au/public/issues/178_06_170303/letters_170303-12.html

HSL1225
Derauf , Dd .
Surely you jest?
BMJ 2003 Mar 15; 325:(7377):1375
http://bmj.com/cgi/eletters/325/7377/1375

HSL1023
Freudenheim M.
Documents Detail Big Payments by Drug Makers to Sway Sales
The New York Times 2003 Mar 13
http://www.nytimes.com/2003/03/13/business/documents-detail-big-payments-by-drug-makers-to-sway-sales.html

HSL1021
Kowalczyk L.
Whistle-blower tells of 'illegal' tactics : Says drug firm taught deception
The Boston Globe 2003 Mar 12

HSL1022
Petersen M.
Pfizer Nears Drug Settlement
The New York Times 2003 Mar 12

HSL5369
Petersen M.
Doctor explains why he blew the whistle
New York Times 2003 Mar 12C1

HSL1020
Friedman R.
Do Spelling and Penmanship Count? In Medicine, You Bet
The New York Times 2003 Mar 11
http://www.nytimes.com/2003/03/11/health/cases-do-spelling-and-penmanship-count-in-medicine-you-bet.html

HSL1177
Vilardell M.
Drug advertising in medical journals.
Lancet 2003 Mar 8; 361:(9360):879

HSL1182
Simmonds H.
Drug advertising in medical journals.
Lancet 2003 Mar 8; 361:(9360):878-9
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-48400HM-18&_coverDate=03%2F08%2F2003&_alid=272343695&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4886&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5cb97991633cfb6b2994c35dbcd55662

HSL1184
Peiró S, Librero J, Villanueva P, Inmaculad P.
Drug advertising in medical journals: Authors' reply
Lancet 2003 Mar 8; 361:(9360):878

HSL1188
Mansfield PR, Lexchin J, Vitry A, Doecke CJ, Svensson S.
Drug advertising in medical journals.
Lancet 2003 Mar 8; 361:(9360):879
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-48400HM-1B&_coverDate=03%2F08%2F2003&_alid=272642718&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4886&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=fa10917712438764944ab5277ec07357

Page 126 of 144 pages ‹ First  < 124 125 126 127 128 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.